Abstract:Human triple negative breast cancer cells, MDA-MB-231, show typical epithelial to mesenchymal transition associated with cancer progression. Mitochondria play a major role in cancer progression, including metastasis. Changes in mitochondrial architecture affect cellular migration, autophagy and apoptosis. Silibinin is reported to have anti-breast cancer effect. We here report that silibinin at lower concentrations (30–90 μM) inhibits epithelial to mesenchymal transition (EMT) of MDA-MB-231, by increasing the expression of epithelial marker, E-cadherin, and decreasing the expression of mesenchymal markers, N-cadherin and vimentin. Besides, silibinin inhibition of cell migration is associated with reduction in the protein expression of matrix metalloproteinases 2 and 9 (MMP2 and MMP9) and paxillin. In addition, silibinin treatment increases mitochondrial fusion through down-regulating the expression of mitochondrial fission-associated protein dynamin-related protein 1 (DRP1) and up-regulating the expression of mitochondrial fusion-associated proteins, optic atrophy 1, mitofusin 1 and mitofusin 2. Silibinin perturbed mitochondrial biogenesis via down-regulating the levels of mitochondrial biogenesis regulators including mitochondrial transcription factor A (TFAM), peroxisome proliferator-activated receptor gamma coactivator (PGC1) and nuclear respiratory factor (NRF2). Moreover, DRP1 knockdown or silibinin inhibited cell migration, and MFN1&2 knockdown restored it. Mitochondrial fusion contributes to silibinin's negative effect on cell migration. Silibinin decreased reactive oxygen species (ROS) generation, leading to inhibition of the NLRP3 inflammasome activation. In addition, knockdown of mitofusin 1&2 (MFN 1&2) relieved silibinin-induced inhibition of NLRP3 inflammasome activation. Repression of ROS contributes to the inhibition of the expression of NLRP3, caspase-1 and IL-β proteins as well as of cell migration. Taken together, our study provides evidence that silibinin impairs mitochondrial dynamics and biogenesis, resulting in reduced migration and invasion of the MDA-MB-231 breast cancer cells.

Suppression of Breast Cancer Invasion and Migration by Indole-3-carbinol: Associated with Up-Regulation of BRCA1 and E-cadherin/catenin Complexes

Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells

Indole-3-Carbinol is a Negative Regulator of Estrogen Receptor-α Signaling in Human Tumor Cells

Indole-3-Carbinol Promotes Apoptosis and Inhibits the Metastasis of Esophageal Squamous Cell Carcinoma by Downregulating the Wnt/β-Catenin Signaling Pathway

Indole-3-Carbinol Is a Negative Regulator of Estrogen

EGFR-dependent Impact of Indol-3-Carbinol on Radiosensitivity of Lung Cancer Cells

Inhibition of Tumor Growth by Dietary Indole-3-Carbinol in a Prostate Cancer Xenograft Model May Be Associated with Disrupted Gut Microbial Interactions

Nutritional Genomics in Cancer Processes Indole-3-Carbinol Is a Negative Regulator of Estrogen 1 , 2

Indole-3-carbinol inhibits cell proliferation and induces apoptosis in Hep-2 laryngeal cancer cells.

In Vitro Suppression of Growth of Murine Wehi-3 Leukemia Cells and in Vivo Promotion of Phagocytosis in A Leukemia Mice Model by Indole-3-Carbinol

Indole-3-carbinol Inhibits Nasopharyngeal Carcinoma Cell Growth in Vivo and in Vitro Through Inhibition of the PI3K/Akt Pathway

EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion

Two likely targets for the anti-cancer effect of indole derivatives from cruciferous vegetables: PI3K/Akt/mTOR signalling pathway and the aryl hydrocarbon receptor

Indole-3-carbinol Blocks Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cell Function and Reduces Neointima Formation in Vivo.

New Derivatives I3C-6 of Indole-3-carbinol in Cervical Cancer HeLa Cells

Identification of the HECT domain binding of indole-3-carbinol (I3C) derivatives for breast cancer therapy

Knockdown of Chloride Channel-3 Inhibits Breast Cancer GrowthIn VitroandIn Vivo

Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion

Indole-3-Carbinol Promotes Goblet-Cell Differentiation Regulating Wnt and Notch Signaling Pathways AhR-Dependently

Indole-3-Carbinol Inhibits Citrobacter Rodentium Infection Through Multiple Pathways Including Reduction of Bacterial Adhesion and Enhancement of Cytotoxic T Cell Activity

Indole-3-carbinol prevents murine colitis development via an IL-22-dependent mechanism that regulates anti-microbial peptides and mucus production